Management of aniridia and iris defects: an update on iris prosthesis options.
Weissbart SB, Ayres BD.
Curr Opin Ophthalmol. 2016 May;27(3):244-9. doi: 10.1097/ICU.0000000000000253.
Aniridia.
Hingorani M, Hanson I, van Heyningen V.
Eur J Hum Genet. 2012 Oct;20(10):1011-7. doi: 10.1038/ejhg.2012.100. Epub 2012 Jun 13.
Flexible silicone artificial iris in cases of aniridia and iris deficiencies.
Roman S, Baudouin C.
J Fr Ophtalmol. 2021 Nov;44(9):1387-1395. doi: 10.1016/j.jfo.2021.02.022. Epub 2021 Jul 27.
Iris reconstruction using artificial iris prosthesis for management of aniridia.
Mostafa YS, Osman AA, Hassanein DH, Zeid AM, Sherif AM.
Eur J Ophthalmol. 2018 Jan;28(1):103-107. doi: 10.5301/ejo.5000991.
Aniridia.
Brauner SC, Walton DS, Chen TC.
Int Ophthalmol Clin. 2008 Spring;48(2):79-85. doi: 10.1097/IIO.0b013e318169314b.
Aniridia congenita.
PINCUS M.
Am J Ophthalmol. 1947 Sep;30(9):1178.
[Congenital aniridia in children].
Bremond-Gignac D.
Rev Prat. 2019 Jan;69(1):67-70.
Artificial iris implantation in congenital aniridia: A systematic review.
Romano D, Bremond-Gignac D, Barbany M, Rahman A, Mauring L, Semeraro F, Cursiefen C, Lagali N, Romano V.
Surv Ophthalmol. 2023 Jul-Aug;68(4):794-808. doi: 10.1016/j.survophthal.2022.11.001. Epub 2022 Nov 12.
Macular involvement in congenital aniridia.
Casas-Llera P, Ruiz-Casas D, Alió JL.
Arch Soc Esp Oftalmol (Engl Ed). 2021 Nov;96 Suppl 1:60-67. doi: 10.1016/j.oftale.2020.11.006. Epub 2021 Jun 4.
Future directions in managing aniridia-associated keratopathy.
van Velthoven AJH, Utheim TP, Notara M, Bremond-Gignac D, Figueiredo FC, Skottman H, Aberdam D, Daniels JT, Ferrari G, Grupcheva C, Koppen C, Parekh M, Ritter T, Romano V, Ferrari S, Cursiefen C, Lagali N, LaPointe VLS, Dickman MM.
Surv Ophthalmol. 2023 Sep-Oct;68(5):940-956. doi: 10.1016/j.survophthal.2023.04.003. Epub 2023 May 4.
